midazolam and kava

midazolam has been researched along with kava in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gardner, SF; Gentry, WB; Gurley, BJ; Hubbard, MA; Khan, IA; Shah, A; Williams, DK1
Gentry, WB; Gurley, BJ; Hartsfield, F; Hubbard, MA; Swain, A; Thaden, J; Tong, Y; Williams, DK1

Trials

2 trial(s) available for midazolam and kava

ArticleYear
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
    Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:5

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Capsules; Cimicifuga; Dietary Supplements; Drug Administration Schedule; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Patient Selection; Phenotype; Time Factors; Valerian

2005
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1

    Topics: Adult; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dietary Supplements; Enzyme Induction; Enzyme Inhibitors; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Models, Biological; Phenotype; Plant Preparations; Rifampin; Risk Assessment; Substrate Specificity

2008